Literature DB >> 1846182

Protease sensitivity and nuclease resistance of the scrapie agent propagated in vitro in neuroblastoma cells.

K Neary1, B Caughey, D Ernst, R E Race, B Chesebro.   

Abstract

The scrapie agent has been propagated in vitro in mouse neuroblastoma cells. To further characterize the tissue culture-derived scrapie agent, we studied the effects of protease and nuclease digestion on the agent derived from these cells. The scrapie agent in these cells was found to be resistant to protease digestions for short times but was inactivated by prolonged digestion at high protease concentrations. In contrast, digestion with a variety of nucleases did not alter the agent titer. These results demonstrate that the agent requires an essential protein or proteins for infectivity. If the agent also contains a nucleic acid genome, it must be more nuclease resistant than the majority of cellular DNA and RNA. These properties of the tissue culture-derived scrapie agent were identical to those of brain-derived scrapie agent and thus cannot be attributed to secondary effects of tissue pathology, since the infected cell cultures show no cytopathic effects as a result of infection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1846182      PMCID: PMC239853     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Amyloid plaques in Creutzfeldt-Jakob disease stain with prion protein antibodies.

Authors:  T Kitamoto; J Tateishi; T Tashima; I Takeshita; R A Barry; S J DeArmond; S B Prusiner
Journal:  Ann Neurol       Date:  1986-08       Impact factor: 10.422

2.  Antibody to scrapie-associated fibril protein identifies a cellular antigen.

Authors:  H J Cho
Journal:  J Gen Virol       Date:  1986-02       Impact factor: 3.891

3.  Characterization of scrapie infection in mouse neuroblastoma cells.

Authors:  R E Race; L H Fadness; B Chesebro
Journal:  J Gen Virol       Date:  1987-05       Impact factor: 3.891

4.  Prion-protein immunoreactivity in human transmissible dementias.

Authors:  G W Roberts; R Lofthouse; R Brown; T J Crow; R A Barry; S B Prusiner
Journal:  N Engl J Med       Date:  1986-11-06       Impact factor: 91.245

5.  Evidence that DNA is present in abnormal tubulofilamentous structures found in scrapie.

Authors:  H K Narang; D M Asher; D C Gajdusek
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

6.  Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins.

Authors:  D A Butler; M R Scott; J M Bockman; D R Borchelt; A Taraboulos; K K Hsiao; D T Kingsbury; S B Prusiner
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

7.  Analyses of frequency of infection, specific infectivity, and prion protein biosynthesis in scrapie-infected neuroblastoma cell clones.

Authors:  R E Race; B Caughey; K Graham; D Ernst; B Chesebro
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

8.  Molecular pathology of scrapie-associated fibril protein (PrP) in mouse brain affected by the ME7 strain of scrapie.

Authors:  J Hope; G Multhaup; L J Reekie; R H Kimberlin; K Beyreuther
Journal:  Eur J Biochem       Date:  1988-03-01

9.  Antisera to scrapie-associated fibril protein and prion protein decorate scrapie-associated fibrils.

Authors:  P A Merz; R J Kascsak; R Rubenstein; R I Carp; H M Wisniewski
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

10.  Evidence suggesting that PrP is not the infectious agent in Creutzfeldt-Jakob disease.

Authors:  L Manuelidis; T Sklaviadis; E E Manuelidis
Journal:  EMBO J       Date:  1987-02       Impact factor: 11.598

View more
  6 in total

1.  N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state.

Authors:  B Caughey; G J Raymond; D Ernst; R E Race
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

2.  Congo red inhibition of scrapie agent replication.

Authors:  B Caughey; D Ernst; R E Race
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

3.  Phosphorylation of prion protein at serine 43 induces prion protein conformational change.

Authors:  Paresa N Giannopoulos; Catherine Robertson; Julie Jodoin; Hemant Paudel; Stephanie A Booth; Andrea C LeBlanc
Journal:  J Neurosci       Date:  2009-07-08       Impact factor: 6.167

4.  Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie.

Authors:  M Fischer; T Rülicke; A Raeber; A Sailer; M Moser; B Oesch; S Brandner; A Aguzzi; C Weissmann
Journal:  EMBO J       Date:  1996-03-15       Impact factor: 11.598

5.  Degradation of the disease-associated prion protein by a serine protease from lichens.

Authors:  Christopher J Johnson; James P Bennett; Steven M Biro; Juan Camilo Duque-Velasquez; Cynthia M Rodriguez; Richard A Bessen; Tonie E Rocke
Journal:  PLoS One       Date:  2011-05-11       Impact factor: 3.240

Review 6.  Prions and related neurological diseases.

Authors:  M Pocchiari
Journal:  Mol Aspects Med       Date:  1994
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.